Is there evidence that upadacitinib helps treat concurrent Vitiligo and alopecia areata?
Vitiligo and alopecia areata are both autoimmune conditions that can occur together. Upadacitinib is a JAK inhibitor that blocks the JAK-STAT pathway, which is involved in the immune attack on melanocytes (vitiligo) and hair follicles (alopecia areata). A published case report provides direct evidence that upadacitinib may help treat both conditions simultaneously, though larger studies are needed.
What the research says
A 2025 case report describes a 57-year-old man with severe atopic dermatitis, extensive vitiligo, and alopecia areata who was treated with upadacitinib 15 mg daily after other therapies failed 4. Within days, his itching stopped. By 15 weeks, his eczema cleared substantially. Eyebrows regrew completely within months, and significant repigmentation of vitiligo patches was seen at one-year follow-up 4. The treatment was well tolerated. This suggests upadacitinib may be effective for concurrent vitiligo and alopecia areata by targeting the shared JAK-STAT pathway 47.
Broader evidence supports upadacitinib's role in inflammatory skin diseases. A network meta-analysis found upadacitinib 30 mg daily was the most effective JAK inhibitor for moderate-to-severe atopic dermatitis 3. A review on vitiligo notes that JAK inhibitors are emerging as adjuncts to phototherapy, though narrowband UVB remains first-line 5. Another review highlights that JAK inhibitors can help restore immune tolerance in vitiligo by targeting T-cell activity 7.
For alopecia areata specifically, the case report shows hair regrowth with upadacitinib 4. While no large trials exist for upadacitinib in alopecia areata alone, the shared JAK-STAT mechanism supports its potential 47. The evidence is currently limited to a single case report, so results may not apply to everyone.
What to ask your doctor
- Could upadacitinib be an option for my vitiligo and alopecia areata together?
- What are the potential side effects of upadacitinib, such as infection risk or lab abnormalities?
- How does upadacitinib compare to other treatments like phototherapy or topical JAK inhibitors for my conditions?
- Are there any ongoing clinical trials for upadacitinib in vitiligo or alopecia areata?
- Should I consider combining upadacitinib with phototherapy for better results?
This question is drawn from common patient questions about Dermatology and answered using cited medical research. We do not provide individualized advice.